Overview

What they do
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception. With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financing rounds. Their companies are based in Europe allowing easy interaction with management. They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
vesaliusbiocapital.com
What they look for
Focuses on therapeutics, medical devices, and diagnostics across Europe, investing across all stages of development from early-stage projects and seed investments to corporate spin-offs, typically acting as a lead or co-lead investor holding a board seat.
vesaliusbiocapital.com
Stage
Seed, Series A, Series B+
vesaliusbiocapital.com
Sectors
Healthcare
vesaliusbiocapital.com
Based
Strassen, LU
vesaliusbiocapital.com

Sources

2026-08-26vesaliusbiocapital.comVesalius Biocapital offers venture capital to young European innovative life science companies
2026-08-26vesaliusbiocapital.comWe may also invest a few hundred thousand euro in a seed project.
2026-08-26vesaliusbiocapital.comBiotechnological Enzymatic Catalyse, Bienca, develops, produces and commercializes enzymatic…
2026-08-26vesaliusbiocapital.comGaston Matthyssens, PhD Managing Partner

Portfolio, cheque size and the rest

The 21 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.

Start free, no cardFree accounts see every record.